Profil
Neil M.
Frazer is the founder of DMK Pharmaceuticals Corp.
(Old).
He worked as a Chief Medical Officer at Chimerix, Inc. and OncoSil Medical Ltd. He also served as a Non-Executive Director & Chief Medical Officer at Immutep Ltd. Mr. Frazer completed his undergraduate degree at The University of Edinburgh.
Anciens postes connus de Neil Frazer
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOSIL MEDICAL LIMITED | Directeur Général | 09/09/2014 |
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology Operates as a clinical stage neuro biotechnology company | Fondateur | - |
| IMMUTEP LIMITED | Directeur Technique/Scientifique/R&D | - |
| CHIMERIX, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Neil Frazer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Chimerix, Inc.
Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Immutep Ltd.
Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
The University of Edinburgh
The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoSil Medical Ltd.
OncoSil Medical Ltd. Medical SpecialtiesHealth Technology Develops and commercializes neurology services including those for pancreatic cancer | Health Technology |
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology Operates as a clinical stage neuro biotechnology company | Health Technology |
















